Annual EBITDA
$206.72M$93.26M+82.19%
Summary
- Current Value
- As of today, PEN annual EBITDA is $206.72M, up +82.19% on
- Historical Performance
- PEN annual EBITDA is up +514.21% over the past 3 years, up +1095.57% over the past 5 years
- All-Time High Comparison
- PEN annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- PEN annual EBITDA is +514.21% above its 3-year low of $33.66M reached on an earlier date
- Sector Comparison
- PEN annual EBITDA is higher than 86.90% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $206.72M | +82.2% | +514.2% | +1095.6% | +5930.3% | |
| Quarterly EBITDA | $42.81M | -5.6% | +193.6% | +152.8% | +2038.3% | |
| TTM EBITDA | $204.16M | +46.7% | +371.4% | +2104.3% | +10000.0% | |
| Price | $328.20 | +20.4% | +7.1% | +32.1% | – | |
| PE Ratio | 75.52 | -70.5% | -96.0% | – | – | |
| Annual Revenue | $1.40B | +17.5% | +65.7% | +150.5% | +1819.1% | |
| Annual EPS | $4.52 | +1167.4% | +8648.6% | +1130.1% | +5559.8% | |
| $189.25M | +119.5% | +3011.6% | +619.3% | +5420.7% | ||
| Annual Net Income | $177.69M | +1168.1% | +8975.5% | +1022.7% | +8974.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $206.72M | at high | |
| 5Y | $206.72M | at high | |
| All | $206.72M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $33.66M | N/A | +514.2% |
| 5Y | -$20.76M | N/A | +1095.6% |
| All | -$20.76M | +1095.6% |
EBITDA History
FAQ
What is the current annual EBITDA of PEN?
As of today, PEN annual EBITDA is $206.72M
What is 1-year change in PEN annual EBITDA?
PEN annual EBITDA is up +82.19% year-over-year
What is 3-year change in PEN annual EBITDA?
PEN annual EBITDA is up +514.21% over the past 3 years
How far is PEN annual EBITDA from its all-time high?
PEN annual EBITDA is currently at its all-time high
How does PEN annual EBITDA rank versus sector peers?
PEN annual EBITDA is higher than 86.90% of companies in Healthcare sector
When is PEN next annual earnings release?
As of today, the next annual earnings release for PEN has not been scheduled
Quarterly EBITDA
$42.81M$20.89M-32.79%
Summary
- Current Value
- As of today, PEN quarterly EBITDA is $42.81M, down -32.79% on
- Historical Performance
- PEN quarterly EBITDA is down -5.64% year-over-year, up +193.55% over the past 3 years
- All-Time High Comparison
- PEN quarterly EBITDA is currently -32.79% below its historical high of $63.69M set on
- 3-Year Low Comparison
- PEN quarterly EBITDA is +1078.96% above its 3-year low of $3.63M reached on
- Sector Comparison
- PEN quarterly EBITDA is higher than 85.20% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $42.81M | -32.8% | -5.6% | +193.6% | +152.8% | |
| Annual EBITDA | $206.72M | – | +82.2% | +514.2% | +1095.6% | |
| TTM EBITDA | $204.16M | -1.2% | +46.7% | +371.4% | +2104.3% | |
| Price | $328.20 | -4.7% | +20.4% | +7.1% | +32.1% | |
| PE Ratio | 75.52 | -0.8% | -70.5% | -96.0% | – | |
| Quarterly Revenue | $374.76M | -2.8% | +15.6% | +55.2% | +121.5% | |
| Quarterly EPS | $0.82 | -31.4% | -17.7% | +276.1% | +161.3% | |
| $38.23M | -35.5% | -5.2% | +377.4% | +184.0% | ||
| Quarterly Net Income | $32.58M | -31.2% | -16.9% | +280.6% | +198.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $63.69M | -32.8% | |
| 3Y | $63.69M | -32.8% | |
| 5Y | $63.69M | -32.8% | |
| All | $63.69M | -32.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $42.81M | at low | |
| 3Y | $3.63M | +1079.0% | |
| 5Y | -$34.30M | +224.8% | |
| All | -$34.30M | +224.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of PEN?
As of today, PEN quarterly EBITDA is $42.81M
What is PEN quarterly EBITDA most recent change?
PEN quarterly EBITDA was down -32.79% on March 31, 2026
What is 1-year change in PEN quarterly EBITDA?
PEN quarterly EBITDA is down -5.64% year-over-year
How far is PEN quarterly EBITDA from its all-time high?
PEN quarterly EBITDA is currently -32.79% below its historical high of $63.69M set on December 31, 2025
How does PEN quarterly EBITDA rank versus sector peers?
PEN quarterly EBITDA is higher than 85.20% of companies in Healthcare sector
When is PEN next earnings release?
The next earnings release for PEN is on
TTM EBITDA
$204.16M$2.56M-1.24%
Summary
- Current Value
- As of today, PEN TTM EBITDA is $204.16M, down -1.24% on
- Historical Performance
- PEN TTM EBITDA is up +46.66% year-over-year, up +371.44% over the past 3 years
- All-Time High Comparison
- PEN TTM EBITDA is currently -1.24% below its historical high of $206.72M set on
- 3-Year Low Comparison
- PEN TTM EBITDA is +371.44% above its 3-year low of $43.31M reached on an earlier date
- Sector Comparison
- PEN TTM EBITDA is higher than 86.03% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $204.16M | -1.2% | +46.7% | +371.4% | +2104.3% | |
| Annual EBITDA | $206.72M | – | +82.2% | +514.2% | +1095.6% | |
| Quarterly EBITDA | $42.81M | -32.8% | -5.6% | +193.6% | +152.8% | |
| Price | $328.20 | -4.7% | +20.4% | +7.1% | +32.1% | |
| PE Ratio | 75.52 | -0.8% | -70.5% | -96.0% | – | |
| TTM Revenue | $1.45B | +3.6% | +17.3% | +64.4% | +145.5% | |
| TTM EPS | $4.35 | -3.9% | +307.6% | +2594.3% | +2677.6% | |
| $187.13M | -1.1% | +63.5% | +931.8% | +893.3% | ||
| TTM Net Income | $171.05M | -3.7% | +305.0% | +2539.2% | +1955.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $206.72M | -1.2% | |
| 3Y | $206.72M | -1.2% | |
| 5Y | $206.72M | -1.2% | |
| All | $206.72M | -1.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $139.21M | N/A | +46.7% |
| 3Y | $43.31M | N/A | +371.4% |
| 5Y | -$15.18M | +1445.4% | |
| All | -$23.55M | +966.9% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of PEN?
As of today, PEN TTM EBITDA is $204.16M
What is PEN TTM EBITDA most recent change?
PEN TTM EBITDA was down -1.24% on March 31, 2026
What is 1-year change in PEN TTM EBITDA?
PEN TTM EBITDA is up +46.66% year-over-year
How far is PEN TTM EBITDA from its all-time high?
PEN TTM EBITDA is currently -1.24% below its historical high of $206.72M set on December 31, 2025
How does PEN TTM EBITDA rank versus sector peers?
PEN TTM EBITDA is higher than 86.03% of companies in Healthcare sector
When is PEN next earnings release?
The next earnings release for PEN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- PEN Official Website www.penumbrainc.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1321732/000132173226000007/0001321732-26-000007-index.htm
- PEN Profile on Yahoo Finance finance.yahoo.com/quote/PEN
- PEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pen